ImmunoCard^® Mycoplasma tests for the presence of IgM antibody to Mycoplasma pneumoniae in human serum using enzyme immunoassay (EIA) technology. The presence of IgM indicates early/acute disease. The presence of IgG (alone or with IgM) is associated with convalescent disease or previous exposure to Mycoplasma with subclinical infection.

The ImmunoCard^® Mycoplasma methodology provides a simple-to-use, self-contained device. No calculations are required and the visual color change makes interpretation of results objective and simple.

Learn more about treatment for Mycoplasma infection